Specifically, Adipo-CARs in MDS patients upregulated several known secreted vasculature-remodeling factors, including, VEGFA and FSTL1, which were also secreted by iMSCs both in CHIP and MDS (Fig. 7B). This evidence concerns the gene VEGFA and myelodysplastic syndrome.